title: Two different perspectives in the management of pT3 and/or margin-positive prostate cancer after radical prostatectomy.
authors.affiliation: Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA. choo.c@mayo.edu
authors.forename: Richard
authors.initials: R
authors.lastname: Choo
authors.forename: Jun
authors.initials: J
authors.lastname: Kawakami
authors.forename: Robert
authors.initials: R
authors.lastname: Siemens
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Davis
authors.forename: Michael
authors.initials: M
authors.lastname: Brundage
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Pisansky
mesh_terms: D000368:Aged; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
chemical_list: D017430:Prostate-Specific Antigen